These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20810034)

  • 1. Resource utilisation and cost of ankylosing spondylitis in Brazil.
    Torres TM; Ferraz MB; Ciconelli RM
    Clin Exp Rheumatol; 2010; 28(4):490-7. PubMed ID: 20810034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and quality of life of patients with ankylosing spondylitis in Canada.
    Kobelt G; Andlin-Sobocki P; Maksymowych WP
    J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource utilization and the cost of rheumatoid arthritis in Brazil.
    Chermont GC; Kowalski SC; Ciconelli RM; Ferraz MB
    Clin Exp Rheumatol; 2008; 26(1):24-31. PubMed ID: 18328143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RAISE study observational and cross sectional study to evaluate the actual reality of the socio-economic impact of ankylosing spondylitis].
    Miranda L; Negreiro F; Queiroz MJ; Silva C
    Acta Reumatol Port; 2008; 33(2):189-97. PubMed ID: 18604185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Hwang WW; Li TK; Lee KK; Li EK
    Rheumatology (Oxford); 2008 Sep; 47(9):1422-5. PubMed ID: 18635597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of ankylosing spondylitis in Spain.
    Kobelt G; Sobocki P; Mulero J; Gratacos J; Pocovi A; Collantes-Estevez E
    Value Health; 2008; 11(3):408-15. PubMed ID: 18489666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey.
    Akkoç N; Direskeneli H; Erdem H; Gül A; Kabasakal Y; Kiraz S; Balkan Tezer D; Hacıbedel B; Hamuryudan V
    Rheumatol Int; 2015 Sep; 35(9):1473-8. PubMed ID: 25749712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
    Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
    Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system.
    Azevedo VF; Rossetto CN; Lorencetti PG; Tramontin MY; Fornazari B; Araújo DV
    Rev Bras Reumatol Engl Ed; 2016; 56(2):131-7. PubMed ID: 27267526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and work limitation of patients with ankylosing spondylitis in China.
    Tu L; Rai JC; Cao S; Lin Z; Hu Z; Gu J
    Clin Exp Rheumatol; 2014; 32(5):661-6. PubMed ID: 25234798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis.
    Ariza-Ariza R; Hernández-Cruz B; Navarro-Sarabia F
    Arthritis Rheum; 2003 Aug; 49(4):483-7. PubMed ID: 12910553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A discrete event modelling framework for simulation of long-term outcomes of sequential treatment strategies for ankylosing spondylitis.
    Tran-Duy A; Boonen A; van de Laar MA; Franke AC; Severens JL
    Ann Rheum Dis; 2011 Dec; 70(12):2111-8. PubMed ID: 21857027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic impact of ankylosing spondylitis in Tunisia.
    Younes M; Jalled A; Aydi Z; Zrour S; Korbaa W; Ben Salah Z; Letaief M; Bejia I; Touzi M; Bergaoui N
    Joint Bone Spine; 2010 Jan; 77(1):41-6. PubMed ID: 20022534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.
    Rivera J; Rejas J; Esteve-Vives J; Vallejo MA;
    Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S39-45. PubMed ID: 20074438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S).
    Zochling J
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S47-58. PubMed ID: 22588768
    [No Abstract]   [Full Text] [Related]  

  • 18. Resource utilization and cost of rheumatic fever.
    Terreri MT; Ferraz MB; Goldenberg J; Len C; Hilário MO
    J Rheumatol; 2001 Jun; 28(6):1394-7. PubMed ID: 11409136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies.
    Cardiel MH; Londoño JD; Gutiérrez E; Pacheco-Tena C; Vázquez-Mellado J; Burgos-Vargas R
    Clin Exp Rheumatol; 2003; 21(4):451-8. PubMed ID: 12942696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom.
    Botteman MF; Hay JW; Luo MP; Curry AS; Wong RL; van Hout BA
    Rheumatology (Oxford); 2007 Aug; 46(8):1320-8. PubMed ID: 17545684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.